CD40LG and COVID-19: Of 397 confirmed COVID-19 cases, 64.48% developed both IgM and IgG antibodies, whereas the number of patients that tested positive for only IgM antibodies was greater than those testing positive for IgG antibodies (18.13% and 6.04%, respectively) [49].